Fund shareholders of DECOY THERAPEUTICS INC
ISIN US79400X6022 · United States · LEI 549300CLUMLZXIHU7X22
- Fund shareholders
- 4
- Of which ETFs
- 1 3 other funds
- Value held
- 79.3K $
- Share of capital
- 1.5 % of 655.2K shares on Aug 12, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 5,156 | 45.9K $ | 0.00 % | 0.79 % | as of May 31, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 4,034 | 29K $ | 0.62 % | as of Jun 30, 2026 ↗ | |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 477 | 4.2K $ | 0.07 % | as of May 31, 2026 ↗ | |
| Horizon Kinetics Medical ETF Listed Funds Trust | 21 | 149.2 $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Horizon Kinetics Medical ETF Listed Funds Trust | 0.00 % | as of Jun 30, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 0.00 % | as of May 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q3 | 4 | +3 | 9,688 | +46,588.0 % |
| 2026Q2 | 1 | 21 |
Institutional managers
4 managers declare this company to the SEC (Form 13F).
| Manager | Shares | Value | |
|---|---|---|---|
| Tower Research Capital LLC (TRC) | 1,021 | 6.7K $ | as of Mar 31, 2026 |
| UBS Group AG | 546 | 3.6K $ | as of Mar 31, 2026 |
| Advisory Services Network, LLC | 41 | 268 $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 1 | 7 $ | as of Mar 31, 2026 |
Declared shareholders of DECOY THERAPEUTICS INC
There is 1 beneficial ownership filing. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Armistice Capital, LLC and 1 other | 9.99 % | 65,503 | as of Jun 30, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Fund shareholders of DECOY THERAPEUTICS INC". https://titelia.com/en/stocks/decoy-therapeutics-inc-US79400X6022